Cellular Engineering Technologies Has Been Awarded a Phase 2 Small Business Innovation Research (SBIR) Grant from the National Institutes of Health

Cellular Engineering Technologies, Inc. (CET), a biotechnology company located in Coralville, Iowa, announces that it has received a Phase 2 SBIR grant from the National Institutes of Health (NIH) to develop commercially safer and more reproducible pluripotent stem cells.

Viewpoint Awarded $2M NCI Phase II SBIR to conduct Phase 1 clinical trial at Mayo Clinic

Viewpoint Molecular Targeting, Inc., a University of Iowa start-up pharmaceutical company that has developed novel therapy and companion diagnostics for cancer, announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Grant valued at $2 million from the National Cancer Institute (NCI) The award will support preclinical development and a Phase 1 clinical imaging trial of it’s VMT01 companion diagnostic in advance of therapeutic trials.

Oregon State University Includes Santos in Graduate Digital Human Modeling Course

IOWA CITY, Iowa -  Following the successful introduction of its first digital human modeling (DHM) course in 2018, Oregon State University (OSU) conducted a successful pilot of a computational ergonomics design course for advanced degrees last year. Now, the School of Mechanical, Industrial and Manufacturing Engineering plans to introduce Santos technologies into Digital Human Modeling for Design.

SantosHuman Inc., U Ottawa, and U Waterloo Partner to Research Canadian Soldier Performance Tool

This year, SantosHuman Inc. will engage in research with the University of Ottawa and the University of Waterloo to develop and validate a tool to predict and optimize performance and minimize injury risk to Canadian Armed Forces (CAF) soldiers based on personal, operational, equipment and environmental factors.

Pages

Subscribe to News & Announcements